Investor Relations

ActiVein represents an attractive investment opportunity, as its dual-function IV catheter. The ActiVein catheter platform has the potential to replace the conventional "Hospital IV" line by enabling both fluid infusion and blood withdrawal:

• Improves patient comfort - By reducing the number of needlestick punctures.
• Improves healthcare efficiency - By freeing up healthcare workers from time previously dedicated
  to taking blood samples.
• Improves healthcare safety - By reducing exposure to needlesticks.
• Targets a large patient population - More than 25 million Americans have peripheral IV catheters placed each year.
• Has a straightforward regulatory pathway (510k) and can be in the market within two-years.

For further information please contact us at info@activein.co.il